Gynaecological malignancies affect women in low and middle income countries (LMICs) at disproportionately higher rates compared with high income countries (HICs) with little known about variations in access, quality, and outcomes in global cancer care. Our study aims to evaluate international variation in post-operative morbidity and mortality following gynaecological oncology surgery between HIC and LMIC settings. Study design consisted of a multicentre, international prospective cohort study of women undergoing surgery for gynaecological malignancies (NCT04579861). Multilevel logistic regression determined relationships within three-level nested-models of patients within hospitals/countries. We enrolled 1820 patients from 73 hospitals in 27 countries. Minor morbidity (Clavien-Dindo I-II) was 26.5% (178/672) and 26.5% (267/1009), whilst major morbidity (Clavien-Dindo III-V) was 8.2% (55/672) and 7% (71/1009) for LMICs/HICs, respectively. Higher minor morbidity was associated with pre-operative mechanical bowel preparation (OR = 1.474, 95%CI = 1.054-2.061, p = 0.023), longer surgeries (OR = 1.253, 95%CI = 1.066-1.472, p = 0.006), greater blood loss (OR = 1.274, 95%CI = 1.081-1.502, p = 0.004). Higher major morbidity was associated with longer surgeries (OR = 1.37, 95%CI = 1.128-1.664, p = 0.002), greater blood loss (OR = 1.398, 95%CI = 1.175-1.664, p ≤ 0.001), and seniority of lead surgeon, with junior surgeons three times more likely to have a major complication (OR = 2.982, 95%CI = 1.509-5.894, p = 0.002). Of all surgeries, 50% versus 25% were performed by junior surgeons in LMICs/HICs, respectively. We conclude that LMICs and HICs were associated with similar post-operative major morbidity. Capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention.

Aberdeen Royal Infirmary NHS Grampian Aberdeen AB25 2ZN UK

Cancer Diseases Hospital Lusaka 10101 Zambia

Department of Gynaecological Oncology Royal London Hospital Barts Health NHS Trust London E1 1FR UK

Department of Obstetrics and Gynaecology 1st Faculty of Medicine Charles University and General University Hospital 121 08 Prague Czech Republic

Institute of Applied Health Sciences University of Aberdeen Aberdeen AB24 3FX UK

Northwestern University in Chicago Chicago IL 60611 USA

UOC Ginecologia Oncologica Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica Fondazione Policlinico Universitario A Gemelli IRCCS 00168 Rome Italy

Wolfson Institute of Population Health Queen Mary University of London London EC1M 6BQ UK

Zobrazit více v PubMed

Gaba F., Bizzarri N., Kamfwa P., Saiz A., Blyuss O., Paranjothy S., Ramirez P.T., Cibula D. Determining post-operative morbidity and mortality following gynecological oncology surgery: Protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative-GO SOAR) Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc. 2021;31:1287–1291. doi: 10.1136/ijgc-2021-002586. PubMed DOI

Knight S.R., Shaw C.A., Pius R., Drake T.M., Norman L., Ademuyiwa A.O., Adisa A.O., Aguilera M.L., Al-Saqqa S.W., Al-Slaibi I., et al. Global variation in postoperative mortality and complications after cancer surgery: A multicentre, prospective cohort study in 82 countries. Lancet. 2021;397:387–397. doi: 10.1016/S0140-6736(21)00001-5. PubMed DOI PMC

Alkire B.C., Shrime M.G., Dare A.J., Vincent J.R., Meara J.G. Global economic consequences of selected surgical diseases: A modelling study. Lancet Glob. Health. 2015;3((Suppl. 2)):S21–S27. doi: 10.1016/S2214-109X(15)70088-4. PubMed DOI PMC

Ghaferi A.A., Birkmeyer J.D., Dimick J.B. Variation in hospital mortality associated with inpatient surgery. N. Engl. J. Med. 2009;361:1368–1375. doi: 10.1056/NEJMsa0903048. PubMed DOI

ESGO ESGO Centre Accreditation For Gynaecological Oncology Training and Surgery. [(accessed on 30 August 2023)]. Available online: https://esgo.org/hospital-training-centre-accreditation/

Burnell M., Iyer R., Gentry-Maharaj A., Nordin A., Liston R., Manchanda R., Das N., Gornall R., Beardmore-Gray A., Hillaby K., et al. Benchmarking of surgical complications in gynaecological oncology: Prospective multicentre study. BJOG Int. J. Obstet. Gynaecol. 2016;123:2171–2180. doi: 10.1111/1471-0528.13994. PubMed DOI

Das N., Talaat A.S., Naik R., Lopes A.D., Godfrey K.A., Hatem M.H., Edmondson R.J. Risk adjusted surgical audit in gynaecological oncology: P-POSSUM does not predict outcome. Eur. J. Surg. Oncol. 2006;32:1135–1138. doi: 10.1016/j.ejso.2006.06.010. PubMed DOI

ECOG-ACRIN Cancer Research Group ECOG Performance Status Scale. [(accessed on 30 August 2023)]. Available online: https://ecog-acrin.org/resources/ecog-performance-status/

Rickard J. Systematic Review of Postgraduate Surgical Education in Low- and Middle-Income Countries. World J. Surg. 2016;40:1324–1335. doi: 10.1007/s00268-016-3445-x. PubMed DOI

Mariani G., Kasznia-Brown J., Paez D., Mikhail M.N., Salama D.H., Bhatla N., Erba P.A., Kashyap R. Improving women’s health in low-income and middle-income countries. Part I: Challenges and priorities. Nucl. Med. Commun. 2017;38:1019–1023. doi: 10.1097/MNM.0000000000000751. PubMed DOI PMC

Saurabh S., Niclas R., Benjamin Ballard M., John G.M., Mark G.S. The impact of physician migration on mortality in low and middle-income countries: An economic modelling study. BMJ Glob. Health. 2020;5:e001535. doi: 10.1136/bmjgh-2019-001535. PubMed DOI PMC

Cheng H., Clymer J.W., Po-Han Chen B., Sadeghirad B., Ferko N.C., Cameron C.G., Hinoul P. Prolonged operative duration is associated with complications: A systematic review and meta-analysis. J. Surg. Res. 2018;229:134–144. doi: 10.1016/j.jss.2018.03.022. PubMed DOI

Wu W.C., Smith T.S., Henderson W.G., Eaton C.B., Poses R.M., Uttley G., Mor V., Sharma S.C., Vezeridis M., Khuri S.F., et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann. Surg. 2010;252:11–17. doi: 10.1097/SLA.0b013e3181e3e43f. PubMed DOI

Mullen M.G., Michaels A.D., Mehaffey J.H., Guidry C.A., Turrentine F.E., Hedrick T.L., Friel C.M. Risk Associated With Complications and Mortality After Urgent Surgery vs Elective and Emergency Surgery: Implications for Defining "Quality" and Reporting Outcomes for Urgent Surgery. JAMA Surg. 2017;152:768–774. doi: 10.1001/jamasurg.2017.0918. PubMed DOI PMC

Shah S.C., Kayamba V., Peek R.M., Jr., Heimburger D. Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? J. Glob. Oncol. 2019;5:1–8. doi: 10.1200/JGO.18.00200. PubMed DOI PMC

Di Donato V., Di Pinto A., Giannini A., Caruso G., D’Oria O., Tomao F., Fischetti M., Perniola G., Palaia I., Muzii L., et al. Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer. Gynecol. Oncol. 2021;161:4–10. doi: 10.1016/j.ygyno.2020.08.022. PubMed DOI

Chao T.E., Mandigo M., Opoku-Anane J., Maine R. Systematic review of laparoscopic surgery in low- and middle-income countries: Benefits, challenges, and strategies. Surg. Endosc. 2016;30:1–10. doi: 10.1007/s00464-015-4201-2. PubMed DOI

Franzen S.R., Chandler C., Lang T. Health research capacity development in low and middle income countries: Reality or rhetoric? A systematic meta-narrative review of the qualitative literature. BMJ Open. 2017;7:e012332. doi: 10.1136/bmjopen-2016-012332. PubMed DOI PMC

Gaba F. Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) Int. J. Gynecol. Cancer. 2022;33:304–305. doi: 10.1136/ijgc-2022-004120. PubMed DOI

Global Forum for Health Research . The 10/90 Report on Health Research 2000. Global Forum for Health Research; Geneva, Switzerland: 2000.

Haier J., Schaefers J. Economic Perspective of Cancer Care and Its Consequences for Vulnerable Groups. Cancers. 2022;14:3158. doi: 10.3390/cancers14133158. PubMed DOI PMC

Yabroff K.R., Mariotto A., Tangka F., Zhao J., Islami F., Sung H., Sherman R.L., Henley S.J., Jemal A., Ward E.M. Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated with Cancer Care. JNCI J. Natl. Cancer Inst. 2021;113:1670–1682. doi: 10.1093/jnci/djab192. PubMed DOI PMC